Show Notes
The Psymposia team discusses the reticence of psychedelic advocates to consider cases of unequivocal abuse and neglect of participants in MAPS clinical trials. We provide background on the gap between the public image of MAPS and the experiences shared by Meaghan, Mel, and Leah in New York Magazine's Cover Story Season 1, Power Trip.
Watch: https://youtu.be/EQRttVF7Dy8
Support:
☼Patreon: http://patreon.com/psymposia ☼Donate: https://www.psymposia.com/donate/
For full episodes, transcripts, supporting documents, and more, visit: https://psymposia.com/powertrip
Follow:
☼Twitter: https://twitter.com/psymposia ☼Instagram: https://www.instagram.com/psymposia/ ☼Facebook: https://www.facebook.com/psymposia ☼Twitch: https://www.twitch.tv/psymposia ☼Website: https://www.psymposia.com ☼Podcast: https://www.psymposia.com/plusthree ☼Newsletter: https://www.psymposia.com/subscribe/
Thank you to our Patreon podcast supporters:
Dave Hodges, James Hubbard, John Hanna, Dave Ayers, Tehseen Noorani, Myster Psoul, Samy Tammam, Amanda Alexander, Maryann Kehoe, Daniel McQueen, Annick McIntosh, Aaron Williams, Julia A, Christian Dawley, Dustin T, Leon Boroditsky, John Bannon, Atticus Kelbley, Daniel, Jason Gross, Clifford Hudson, Miller Hooks, Scott Martin, Sandra Dreisbach, zeph Tam, Rochella Martin, Gurpreet Saini, Jason Seidel, Will Petersen, Jeff Davis
More from The Psymposia Podcast
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony. Footnotes: Submit written comment to the FDA by October 5, 2026 https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene. Footnotes: Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex's 'Undoing'? (Rolling Stone): https://www.rollingstone.com/tv-movies/tv-movie-features/reggie-watts-ketamine-drug-advocate-1235607828/ Ending The Silence Around Psychedelic Therapy Abuse (Mad In America): https://www.madinamerica.com/2021/09/ending-silence-psychedelic-therapy-abuse/ Cover Story: Power Trip (Psymposia): https://www.psymposia.com/powertrip-2/ The Psychedelic Syndicate (Psymposia): https://www.psymposia.com/psychedelic-syndicate-executive-summary-silicon-valley-maps-lykos-mdma-fda-billionaires/index.html
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films. Thumbnail terminator image provided by Alex Novell.
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.